Four steps to asthma treatment


Montelukast works by blocking the action of chemicals released by the body as part of allergic and inflammatory reactions

Scientists based in the US have devised a new way to make Montelukast, a drug used in the treatment of asthma and seasonal allergies.1

Asthma is a chronic inflammatory disease of the airways which affects up to 300 million people worldwide and caused 250,000 deaths in 2011. Although there is no cure for asthma, symptoms can be managed through the use of fast-acting medication to treat acute attacks, and long-term control achieved using inhaled corticosteroids, sometimes in conjunction with a leukotriene antagonist, such as Montelukast.

The synthesis of Montelukast, reported in 1993 by scientists at Merck, involves 10 steps.2 The more steps required to manufacture a drug, the more costly and time-consuming the process becomes. Shorter, more efficient drug syntheses are therefore highly sought after by pharmaceutical companies.

James White and Subrata Shaw at Oregon State University have developed a new synthetic pathway to Montelukast, in which the drug is prepared in only four steps. Their synthesis is more efficient than the Merck route as the latter introduces the sulfur substituent indirectly and non-catalytically via a displacement reaction. White and Shaw incorporated the sulfur substituent directly via an enantioselective sulfa-Michael reaction using an iron(III)–salen catalyst.

Introducing the sulfur substituent directly using an iron(III)–salen catalyst is key to streamlining the synthesis

Daniel Seidel, an expert in asymmetric catalysis at Rutgers University in the US is particularly impressed by the broad scope and high enantioselectivity and diastereoselectivity of the iron(III)–salen-based reaction, describing it as an excellent general solution to a challenging problem.

White hopes to use the bicyclic scaffold that forms the chiral centerpiece of the salen-metal complexes as a template to formulate asymmetric catalysts for other transformations including cyclopropanation and the Conia-ene reaction.

 

 


Related Content

The sultan of synthesis

11 April 2014 Feature

news image

Phil Baran is spurring organic chemists to rethink how they make complex compounds, as Mark Peplow discovers

Principles of asymmetric synthesis (2nd edition)

5 July 2013 Review

news image

Chiral choreography

Most Read

US government science institute's one time police chief linked to campus meth lab

31 July 2015 News and Analysis

news image

Explosion injuring a member of the National Institute of Standards and Technology's security force uncovered methamphetamine ...

Antifreeze polymer protects cells as they thaw

29 July 2015 Research

news image

Simple synthetic polymer found to enhance cryopreservation of red blood cells by inhibiting ice crystal growth

Most Commented

Philae poses comet chemistry conundrum

30 July 2015 Research

news image

Historic mass spectra find 67P carries precursors to key biomolecules, but instruments detect different ones

Butterfly population collapse prompts lawsuit against EPA

5 March 2015 News and Analysis

news image

US agency criticised for failing to investigate link between glyphosate and the dwindling monarch butterfly population